Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Mobilization and Outcomes After Venous Closure

The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.

Participants needed: 300
Trial details
Biological sex: AllType: ObservationalSponsor: Cordis US Corp.Updated: Mar 16, 2026Locations: 3Duration: 14 Days
Eligibility criteria

Able and willing to provide informed consent and to complete a follow-up visit a... [+3]

Presence of bruit, palpable aneurysm, significant candida or groin infection. [+4]

Status: Not yet recruiting

Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery Disease

The purpose of this study is to evaluate long-term safety and performance per the intended use of the S.M.A.R.T.™ Nitinol Stent System (SMART 120/150), S.M.A.R.T.™ CONTROL™ Nitinol Stent System (SMART CONTROL) and S.M.A.R.T.™ Flex Vascular Stent System (SMART Flex) in the treatment of iliac and femoropopliteal artery disease.

Participants needed: 240
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cordis US Corp.Updated: Jan 14, 2026Locations: 1
Eligibility criteria

Subjects treated with SMART 120/150, SMART CONTROL or SMART Flex according to th... [+1]

Women who were pregnant or lactating at the time of the procedure. [+1]